ATRX immunostaining predicts IDH and H3F3A status in gliomas
Crossref DOI link: https://doi.org/10.1186/s40478-016-0331-6
Published Online: 2016-06-16
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ebrahimi, Azadeh
Skardelly, Marco
Bonzheim, Irina
Ott, Ines
Mühleisen, Helmut
Eckert, Franziska
Tabatabai, Ghazaleh
Schittenhelm, Jens
Funding for this research was provided by:
Else Übelmesser Foundation for Applied Cancer Research (D.30.19845)
